|
Antivirals
 
Blocks Viral Attachment, Penetration, or Uncoating
 Class Name of Drug(s) Indications
Amantadine
  • Amantadine
  • Rimantadine
  • Influenza A
Fusion inhibitors
  • Enfuvirtide
  • Maraviroc
  • HIV
Viral DNA Polymerase Inhibitors
Acyclovir
  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • HSV
  • VZV
  • EBV
Ganciclovir
  • Ganciclovir
  • CMV
Foscarnet
  • Foscarnet
  • Second line drug for CMV and HSV
Cidofovir
  • Cidofovir 
  • Second line drug for CMV and HSV
Viral RNA Polymerase Inhibitors
Ribavirin
  • Ribavirin
  • Chronic hepatitis C
  • RSV
  • Viral hemorrhagic fevers
Reverse Transcriptase Inhibitors (RTIs)
Nucleoside RTIs
  • Zidovudine
  • Didanosine
  • Zalcitabine
  • Lamivudine
  • Stavudine
  • HAART (HIV)
Non-nucleoside RTIs
  • Nevirapine
  • Efavirenz
  • HAART (HIV)
Protease Inhibitors
Protease inhibitors
  • Saquinavir
  • Ritonavir
  • Indinavir
  • Nelfinavir
  • Amprenavir
  • HAART (HIV)
Blocks Viral Release
Neuraminidase inhibitors
  • Oseltamivir
  • Zanamivir
  • Influenza A and B
 

Please rate topic.

Average 5.0 of 2 Ratings

Questions (1)

(M1.MC.75) A thymidine kinase-deficient varicella-zoster virus strain has been isolated at a retirement home. Many of the elderly had been infected with this strain and are experiencing shingles. Which of the following would be the best antiviral agent to treat this population? Review Topic

QID: 106859
1

Acyclovir

23%

(3/13)

2

Famciclovir

38%

(5/13)

3

Ganciclovir

15%

(2/13)

4

Cidofovir

23%

(3/13)

5

Amantadine

0%

(0/13)

Select Answer to see Preferred Response

PREFERRED RESPONSE 4
EVIDENCE & REFERENCES (2)
VIDEOS (1)
Topic COMMENTS (3)
Private Note